Zydus Sets Sight On First US Generic Of UCB’s Briviact

FDA Approves Brivaracetam ANDA With Shared 180-Day Exclusivity

 
• By Dean Rudge
  
UCB flag
UCB's epilepsy portfolio is core to the originator • Source: UCB

More from Generics

More from Products